Chelsea Therapeutics International Ltd. (NASDAQ:CHTP)

CAPS Rating: 2 out of 5

A development stage pharmaceutical company that seeks to acquire and develop innovative products for the treatment of a variety of human diseases.

Recs

0
Player Avatar OklaBoston (68.78) Submitted: 12/5/2012 6:34:41 PM : Outperform Start Price: $0.96 CHTP Score: -8.40

This "Hot 1 Star" was added to Zacks.com's "Strong Buy" list today. Zero debt and a Current Ratio of 5.5 are also attractive.

Featured Broker Partners


Advertisement